Tower View Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,650
Closed -$183K 188
2022
Q1
$183K Buy
1,650
+25
+2% +$2.64K 0.1% 79
2021
Q4
$168K Sell
1,625
-15,659
-91% -$1.81M 0.09% 82
2021
Q3
$2.17M Buy
17,284
+1,897
+12% +$246K 1.2% 37
2021
Q2
$1.91M Buy
15,387
+12,502
+433% +$1.57M 0.97% 42
2021
Q1
$341K Buy
2,885
+136
+5% +$15.9K 0.19% 76
2020
Q4
$322K Buy
2,749
+245
+10% +$27K 0.18% 72
2020
Q3
$260K Buy
2,504
+125
+5% +$12.6K 0.17% 69
2020
Q2
$218K Buy
2,379
+694
+41% +$66.5K 0.16% 63
2020
Q1
$152K Buy
1,685
+975
+137% +$104K 0.14% 62
2019
Q4
$81K Buy
710
+65
+10% +$7.13K 0.06% 78
2019
Q3
$70K Buy
645
+225
+54% +$23.5K 0.06% 77
2019
Q2
$41K Buy
420
+354
+536% +$32.3K 0.04% 80
2019
Q1
$6K Buy
+66
New +$5.91K 0.01% 120

Other funds holding MDT

Tower View Wealth Management's MDT Position: Q2 2022 in Review

Tower View Wealth Management sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,650 shares — an estimated $183K sold.

Tower View Wealth Management first reported a position in MDT in Q1 2019 and held it in 13 quarters. The position peaked at $2.17M in Q3 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Tower View Wealth Management reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Tower View Wealth Management sold 1,650 Medtronic shares in Q2 2022, an estimated $183K.
  • Tower View Wealth Management first reported a position in Medtronic in Q1 2019 and held it in 13 quarters.
  • Tower View Wealth Management's Medtronic position peaked at $2.17M in Q3 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Tower View Wealth Management's 13F filing for Q2 2022, filed 8 Aug 2022.